Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AVEO Pharmaceuticals Inc. (AVEO)

0.644   -0.063 (-8.85%) 11-14 16:00
Open: 0.7 Pre. Close: 0.7065
High: 0.7 Low: 0.6
Volume: 3,566,939 Market Cap: 94M
AVEO Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.701 - 0.704 0.704 - 0.706
Low: 0.593 - 0.597 0.597 - 0.599
Close: 0.634 - 0.64 0.64 - 0.645

Technical analysis

as of: 2019-11-14 4:27:19 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.90     One year: 1.12
Support: Support1: 0.47    Support2: 0.39
Resistance: Resistance1: 0.77    Resistance2: 0.96
Pivot: 0.70
Moving Average: MA(5): 0.59     MA(20): 0.76
MA(100): 0.76     MA(250): 0.98
MACD: MACD(12,26): -0.07     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 34.93     %D(3): 24.61
RSI: RSI(14): 41.75
52-week: High: 2.25  Low: 0.47  Change(%): -65.4
Average Vol(K): 3-Month: 276410  10-Days: 528747

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AVEO has closed above bottom band by 41.2%. Bollinger Bands are 202.7% wider than normal. The large width of the bands suggest high volatility as compared to AVEO's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Tue, 05 Nov 2019 06:30:43 +0000
FDA Says "Not Now AVEO", HALO Axes 160 Jobs, RDHL Gets Nod For H.pylori Drug

Tue, 02 Apr 2019 21:44:25 +0000
5 Top Gainers In Healthcare Sector (AVEO, EDAP, ZYNE...)

Wed, 27 Mar 2019 18:39:46 +0000
Mid-Afternoon Market Update: Shoe Carnival Surges On Upbeat Q4 Results; Inpixon Shares Plunge

Wed, 27 Mar 2019 16:34:37 +0000
Mid-Day Market Update: Crude Oil Down Over 1%; Syndax Pharmaceuticals Shares Spike Higher

Fri, 29 Mar 2019 08:47:00 +0000
AVEO Pharmaceuticals (AVEO) to File NDA for Fotivda with FDA

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 160.74
Shares Float (M) 134.84
% Held by Insiders 0.28
% Held by Institutions 32.51
Shares Short (K) 17240
Shares Short P. Month (K)

Stock Financials

EPS -0.101
Book Value (p.s.) 0.010
PEG Ratio
Profit Margin -46.69
Operating Margin -388.65
Return on Assets (ttm) -49.3
Return on Equity (ttm)
Qtrly Rev. Growth 62.4
Gross Profit (p.s.) -0.095
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -23.89
Levered Free Cash Flow (M) -17.65

Stock Valuations

P/E -6.33
P/E Growth Ratio -0.10
P/BV 63.94
P/S 12.78
P/CF -4.30

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.